Author:
Furukawa Koichi,Furukawa Keiko,Ohmi Yuhsuke,Ohkawa Yuki,Yamauchi Yoshio,Hashimoto Noboru,Tajima Orie
Reference57 articles.
1. Becker JC, Pancook JD, Gillies SD, Furukawa K, Reisfeld RA (1996a) T cell-mediated eradication of murine metastatic melanoma induced by targeted interleukin 2 therapy. J Exp Med 183:2361–2366
2. Becker JC, Varki N, Gillies SD, Furukawa K, Reisfeld RA (1996b) Long-lived and transferable tumor immunity in mice following targeted interleukin 2 therapy. J Clin Invest 98:2801–2804
3. Blanchard D, Cartron JP, Fournet B, Montreuil J, van Halbeek H, Vliegenthart JF (1983) Primary structure of the oligosaccharide determinant of blood group Cad specificity. J Biol Chem 258:7691–7695
4. Bowes T, Wagner ER, Boffey J, Nicholl D, Cochrane L, Benboubetra M, Conner J, Furukawa K, Furukawa K, Willison HJ (2002) Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome. Infect Immun 70:5008–5018
5. Cheung NK, Saarinen UM, Neely JE, Landmeier B, Donovan D, Coccia PF (1985) Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells. Cancer Res 45:2642–2649